This site is intended for managed care professionals in the U.S.
Professionals in Canada should visit CanadaCGM.com
Source: BMJ Open Diabetes Research and Care
Key takeaway: A real-life observational study demonstrated the effectiveness of flash glucose monitoring (FGM) in participants with diabetes over a 12 month period. Data from the Netherlands Nationwide Registry showed the use of FGM results in improved well-being, decreased disease burden, and is associated with a 0.4% reduction of HbA1c after 12 months (p < 0.001). Results from a patient-reported outcome measures questionnaire revealed significant reductions in work absenteeism and diabetes-related hospital admissions.
This web site is supported by an educational grant from DexCom, Inc.